|
FY2022
12 months to Jan 2, 2022
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net loss | |
| Adjustments to reconcile net loss to cash provided by operating activities: | |
| Depreciation and amortization | |
| Unrealized and non-cash foreign exchange losses (gains), net | |
| Amortization of deferred financing costs and original issue discount | |
| Deferred tax benefit | |
| Stock based compensation | |
| Change in allowance for credit losses | |
| Loss on extinguishment of debt | |
| Other non-cash, net | |
| Changes in operating assets and liabilities, net of effects of acquisitions: | |
| Accounts receivable | |
| Inventories | |
| Other current and non-current assets | |
| Accounts payable and accrued liabilities | |
| Deferred revenue | |
| Other current and non-current liabilities | |
| Cash provided by operating activities | |
| Cash Flows from Investing Activities: | |
| Purchase of property, plant and equipment | |
| Proceeds from cross-currency swaps | |
| Milestone payments and other, net | |
| Cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds From Issuance Initial Public Offering | |
| Payment of initial public offering costs | |
| Proceeds from long-term debt | |
| Payments on long-term debt | |
| (Payments) borrowings on short-term borrowings, net | |
| Proceeds from exercise of stock options | |
| Repurchase of common stock | |
| Cash provided by (used in) financing activities | |
| Effect of exchange rate changes on cash | |
| Increase (decrease) in cash, cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash at beginning of year | |
| Cash, cash equivalents and restricted cash at end of year | |
| Cash and cash equivalents | |
| Restricted cash included in Other assets |
Loading...
